All In Biotech

Drug Trial Radar · NCT06709196

Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis

REINFORCE - Reducing Infection-related Readmissions Following Cystectomy. a Multicentre Randomised Clinical Trial Testing Superiority of Individualised Targeted Antibiotic Prophylaxis Over Empiric Prophylaxis At Ureteral Stent Removal to Reduce Infection-related Readmissions Following Cystectomy.

Last checked: Nov 20, 2026Latest source record: Jan 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 248 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

248

Planned (sponsor's estimate)

Start

Jan 7, 2025

Primary completion

Jan 2027

Study completion Jan 2027

Sponsor

Lead sponsor
Copenhagen University Hospital, RigshospitaletAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 29, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this trial is to test whether postoperative antibiotics targeted towards bacteria in the urine can reduce the risk of infection after surgical removal of the bladder (cystectomy) compared to a standardised antibiotic prophylaxis. Participants undergoing cystectomy will be randomly assigned to postoperatively receive (A) a standardised orally administered antibiotic prophylaxis currently given at Rigshospitalet, Copenhagen or (B) a conventional orally administered antibiotic prophylaxis targeting bacteria found in the urine postoperatively. The investigators' hypothesis is that the targeted prophylactic antibiotic strategy will reduce the number of infection-related readmissions within 90 days of surgery compared to the standardised prophylaxis.

Conditions

  • Cystectomy
  • Bladder Cancer Requiring Cystectomy
  • Postoperative Infections
  • Antibiotic Prophylaxis
  • Ileal Conduit

Interventions

  • PivmecillinamDrug

    Orally administered pivmecillinam 400mg

  • PivmecillinamDrug

    Orally administered targeted antimicrobial prophylaxis based on a urine culture.

  • Amoxicillin clavulanic acidDrug

    Orally administered targeted antimicrobial prophylaxis based on a urine culture.

  • AmoxicillinDrug

    Orally administered targeted antimicrobial prophylaxis based on a urine culture.

  • CefuroximeDrug

    Orally administered targeted antimicrobial prophylaxis based on a urine culture.

  • CiprofloxacinDrug

    Orally administered targeted antimicrobial prophylaxis based on a urine culture.

  • LinezolidDrug

    Orally administered targeted antimicrobial prophylaxis based on a urine culture.

  • NitrofurantoinDrug

    Orally administered targeted antimicrobial prophylaxis based on a urine culture.

  • TrimethoprimDrug

    Orally administered targeted antimicrobial prophylaxis based on a urine culture.

  • Sulfamethoxazole trimethoprimDrug

    Orally administered targeted antimicrobial prophylaxis based on a urine culture.

  • FluconazoleDrug

    Orally administered targeted antimicrobial prophylaxis based on a urine culture.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Infection-related readmission rateTime frame: 90 days after surgery

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Department of Urology, Aalborg University Hospital

    Aalborg, Denmark · Not yet recruiting

  • Department of Urology, Aarhus University Hospital

    Aarhus, Denmark · Not yet recruiting

  • Department of Urology, Rigshospitalet

    Copenhagen, Denmark · Recruiting

  • Department of Urology, Herlev and Gentofte Hospital

    Herlev, Denmark · Not yet recruiting

  • Department of Urology, Odense University Hospital

    Odense, Denmark · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.